Literature DB >> 8687415

Arachidonic acid and lipoxygenase products stimulate protein kinase C beta mRNA levels in pituitary alpha T3-1 cell line: role in gonadotropin-releasing hormone action.

Z Shraga-Levine1, D Ben-Menahem, Z Naor.   

Abstract

The cross-talk of arachidonic acid (AA) and its lipoxygenase products with protein kinase C beta (PKC beta) mRNA levels during the action of gonadotropin-releasing hormone (GnRH) was investigated in the pituitary alpha T3-1 cell line. The addition of AA or its 5-lipoxygenase products 5-hydroxyeicosatetraenoic acid (5-HETE) or leukotriene C4 (LTC4) for 30 or 60 min stimulated PCK beta, but not PKC alpha mRNA levels (3-5-fold); PCK gamma is not expressed by the cells. Other HETEs or leukotrienes tested showed no significant effect. The range of effective concentration for LTC4 and 5-HETE (around 10(-10) M) is the range found in GnRH-stimulated pituitary cells. Although PKC beta mRNA levels were preferentially elevated by LTC4 and 5-HETE at early time points, PKC alpha mRNA levels were elevated at 6-12 h of incubation when PKC beta mRNA levels returned to basal levels. The addition of the phospholipase A2 inhibitor 4-bromophenacyl bromide or the selective 5-lipoxygenase inhibitor L-656,224 abolished [D-Trp6]GnRH (GnRH-A) elevation of PKC beta mRNA levels, whereas PKC alpha mRNA levels were not increased by this neurohormone. The cyclo-oxygenase inhibitor indomethacin elevated basal PKC beta mRNA levels and potentiated the GnRH-A response. Cross-talk exists between AA and some of its lipoxygenase products and PKC beta gene expression during cell signalling. AA, 5-HETE and LTC4 participate in the rapid stimulation of PKC beta mRNA levels by GnRH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687415      PMCID: PMC1217399          DOI: 10.1042/bj3160667

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

Review 1.  Gonadotropin-releasing hormone receptors: structure and signal transduction pathways.

Authors:  S S Stojilkovic; J Reinhart; K J Catt
Journal:  Endocr Rev       Date:  1994-08       Impact factor: 19.871

Review 2.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

3.  Leukotriene B4 stimulation of phagocytes results in the formation of inositol 1,4,5-trisphosphate. A second messenger for Ca2+ mobilization.

Authors:  T Andersson; W Schlegel; A Monod; K H Krause; O Stendahl; D P Lew
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

4.  Leukotriene C4 as a mediator of luteinizing hormone release from rat anterior pituitary cells.

Authors:  A L Hulting; J A Lindgren; T Hökfelt; P Eneroth; S Werner; C Patrono; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Mechanism of action of gonadotropin releasing hormone: role of lipoxygenase products of arachidonic acid in luteinizing hormone release.

Authors:  Z Naor; L Kiesel; J Y Vanderhoek; K J Catt
Journal:  J Steroid Biochem       Date:  1985-11       Impact factor: 4.292

6.  A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase.

Authors:  L C McPhail; C C Clayton; R Snyderman
Journal:  Science       Date:  1984-05-11       Impact factor: 47.728

7.  Mechanism of action of gonadotropin-releasing hormone. Involvement of phospholipid turnover in luteinizing hormone release.

Authors:  Z Naor; K J Catt
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

8.  Selective activation of the gamma-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites.

Authors:  M S Shearman; Z Naor; K Sekiguchi; A Kishimoto; Y Nishizuka
Journal:  FEBS Lett       Date:  1989-01-30       Impact factor: 4.124

9.  L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3- methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitor.

Authors:  P Belanger; A Maycock; Y Guindon; T Bach; A L Dollob; C Dufresne; A W Ford-Hutchinson; P H Gale; S Hopple; C K Lau
Journal:  Can J Physiol Pharmacol       Date:  1987-12       Impact factor: 2.273

10.  Calcium-independent activation of hypothalamic type I protein kinase C by unsaturated fatty acids.

Authors:  Z Naor; M S Shearman; A Kishimoto; Y Nishizuka
Journal:  Mol Endocrinol       Date:  1988-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.